Genetically proxied ketohexokinase function and risk of colorectal cancer: a Mendelian randomisation study

Amée M Buziau^{1

2

3}, Philip J Law⁴, Gabriella Blokland⁵, Casper Schalkwijk^{2

3}, Jean Scheijen^{2

3}, Pomme Simons^{1

2

3}, Carla van der Kallen^{2

6}, Simone Eussen^{2

7

8}, Pieter C Dagnelie^{2

6}, Marleen van Greevenbroek^{2

3}, Richard S Houlston⁴, Anke Wesselius^{9

10}, Molly Went⁴, Coen Stehouwer^{2

6}, Martijn Cgj Brouwers^{11

2}

Affiliations

¹ Department of Internal Medicine, division of Endocrinology and Metabolic Disease, Maastricht University Medical Centre, Maastricht, The Netherlands.
² CARIM School for Cardiovascular disease, Maastricht University, Maastricht, The Netherlands.
³ Department of Internal Medicine, Division of General Internal Medicine, Laboratory for Metabolism and Vascular Medicine, Maastricht University, Maastricht, The Netherlands.
⁴ Division of Genetics and Epidemiology, The Institute of Cancer Research, London SW7 3RP, UK.
⁵ Department of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience, Maastricht University, Maastricht, The Netherlands.
⁶ Department of Internal Medicine, Maastricht University Medical Centre, Maastricht, The Netherlands.
⁷ Department of Epidemiology, Maastricht University, Maastricht, The Netherlands.
⁸ CAPHRI Care and Public Health Research Institute, Maastricht University, Maastricht, The Netherlands.
⁹ NUTRIM School for Nutrition and Translational Research in Metabolism, Maastricht University, Maastricht, The Netherlands.
¹⁰ Department of Complex Genetics and Epidemiology, Maastricht University, Maastricht, The Netherlands.
¹¹ Department of Internal Medicine, division of Endocrinology and Metabolic Disease, Maastricht University Medical Centre, Maastricht, The Netherlands mcgj.brouwers@mumc.nl.

PMID: 35537810
DOI: 10.1136/gutjnl-2021-326299

Comment

Genetically proxied ketohexokinase function and risk of colorectal cancer: a Mendelian randomisation study

Amée M Buziau et al. Gut. 2023 Mar.

. 2023 Mar;72(3):604-606.

doi: 10.1136/gutjnl-2021-326299. Epub 2022 May 10.

Authors

Affiliations

¹ Department of Internal Medicine, division of Endocrinology and Metabolic Disease, Maastricht University Medical Centre, Maastricht, The Netherlands.
² CARIM School for Cardiovascular disease, Maastricht University, Maastricht, The Netherlands.
³ Department of Internal Medicine, Division of General Internal Medicine, Laboratory for Metabolism and Vascular Medicine, Maastricht University, Maastricht, The Netherlands.
⁴ Division of Genetics and Epidemiology, The Institute of Cancer Research, London SW7 3RP, UK.
⁵ Department of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience, Maastricht University, Maastricht, The Netherlands.
⁶ Department of Internal Medicine, Maastricht University Medical Centre, Maastricht, The Netherlands.
⁷ Department of Epidemiology, Maastricht University, Maastricht, The Netherlands.
⁸ CAPHRI Care and Public Health Research Institute, Maastricht University, Maastricht, The Netherlands.
⁹ NUTRIM School for Nutrition and Translational Research in Metabolism, Maastricht University, Maastricht, The Netherlands.
¹⁰ Department of Complex Genetics and Epidemiology, Maastricht University, Maastricht, The Netherlands.
¹¹ Department of Internal Medicine, division of Endocrinology and Metabolic Disease, Maastricht University Medical Centre, Maastricht, The Netherlands mcgj.brouwers@mumc.nl.

PMID: 35537810
DOI: 10.1136/gutjnl-2021-326299

No abstract available

Keywords: COLORECTAL CANCER; GENETIC POLYMORPHISMS; NUTRITION.

PubMed Disclaimer

Conflict of interest statement

Competing interests: None declared.

Comment on

Sugar-sweetened beverage intake in adulthood and adolescence and risk of early-onset colorectal cancer among women.
Hur J, Otegbeye E, Joh HK, Nimptsch K, Ng K, Ogino S, Meyerhardt JA, Chan AT, Willett WC, Wu K, Giovannucci E, Cao Y. Hur J, et al. Gut. 2021 Dec;70(12):2330-2336. doi: 10.1136/gutjnl-2020-323450. Epub 2021 May 6. Gut. 2021. PMID: 33958435 Free PMC article.

Cited by

Steatotic liver disease interacts with a polygenic risk score for triglyceride clearance to impact the risk of hypertriglyceridaemia: The Maastricht Study.
Ren Z, Wesselius A, Kooi ME, van Greevenbroek M, Dagnelie P, Berendschot TTJM, Kroon AA, Houben AJHM, Stehouwer CDA, Brouwers MCGJ. Ren Z, et al. Diabetologia. 2025 Jun 27. doi: 10.1007/s00125-025-06479-3. Online ahead of print. Diabetologia. 2025. PMID: 40579639
Fructose restriction has beneficial effects on adipose tissue distribution but not on serum adipokine levels: Post-hoc analysis of a double-blind randomized controlled trial.
van Oeteren MAJ, Simons N, Simons PIHG, van de Waarenburg MPH, Kooi ME, Feskens EJM, van der Ploeg EMCL, Van den Eynde MDG, Houben AJHM, Schalkwijk CG, Brouwers MCGJ. van Oeteren MAJ, et al. Clin Obes. 2025 Feb;15(1):e12714. doi: 10.1111/cob.12714. Epub 2024 Oct 28. Clin Obes. 2025. PMID: 39468417 Free PMC article. Clinical Trial.

Publication types

Actions
Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions

Grants and funding

25514/CRUK_/Cancer Research UK/United Kingdom

LinkOut - more resources

Full Text Sources
- HighWire
- Ovid Technologies, Inc.
Medical
- MedlinePlus Health Information

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Genetically proxied ketohexokinase function and risk of colorectal cancer: a Mendelian randomisation study

Affiliations

Genetically proxied ketohexokinase function and risk of colorectal cancer: a Mendelian randomisation study

Authors

Affiliations

Conflict of interest statement

Comment on

Similar articles

Cited by

Publication types

MeSH terms

Grants and funding

LinkOut - more resources

Full Text Sources

Medical